Colorectal Cancer Clinical Trials in Kansas City, MO

Colorectal Cancer Clinical Trials in Kansas City, MO

View the best 10 colorectal cancer medical studies in Kansas City, Missouri. Access promising new therapies by applying to a Kansas City-based Colorectal Cancer clinical trial.

Trials in Kansas City, Missouri

Here are the top 10 medical studies for colorectal cancer in Kansas City, Missouri

Image of South Texas Accelerated Research Therapeutics in San Antonio, United States.

SGN-MesoC2

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial is looking at a new drug called SGN-MesoC2 for treating advanced solid tumors, which are cancers that have grown in one place or spread to other parts of the body. Patients
Image of Mayo Clinic Hospital in Arizona in Phoenix, United States.

Adenovirus 5 CEA/MUC1/Brachyury Vaccine Tri-Ad5

Cancer Vaccine

Recruiting0 awardsPhase 2
This trial tests a vaccine and an immune booster to prevent cancer in people with Lynch syndrome. The vaccine teaches the body to fight cancer, and the booster makes this process stronger. Vaccines have shown robust potential for preventing Lynch syndrome cancers.
Image of National Institutes of Health Clinical Center in Bethesda, United States.

Metarrestin

Small Molecule

Recruiting1 awardPhase 1
This trial is studying a drug called metarrestin as a possible treatment for metastatic cancer.
Image of University of California Davis in Sacramento, United States.

Tisotumab Vedotin

Antibody-Drug Conjugate

Recruiting1 awardPhase 2
This trial will study tisotumab vedotin to find out whether it is an effective treatment for certain solid tumors and what side effects (unwanted effects) may occur. There are four parts to this study.
Image of Central Alabama Research in Birmingham, United States.

Fruquintinib

Tyrosine Kinase Inhibitor

Recruiting3 awardsPhase 4
"This trial aims to investigate the frequency of high blood pressure in minority groups like Black/African American and Hispanic/Latino individuals with refractory metastatic colorectal cancer after treatment with fruquint
Image of Sarcoma Oncology in Santa Monica, United States.

HBI-2438

Epigenetic Modulator

Recruiting1 awardPhase 1
This trial tests HBI-2438, an oral drug for patients with advanced solid tumors having the KRAS G12C mutation. The drug aims to stop cancer growth by blocking the faulty gene. Related drugs, Adagrasib and Sotorasib, have shown effectiveness in treating similar conditions.
Image of UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, United States.

9-ING-41

GSK-3β inhibitor

Recruiting1 awardPhase 2
This trial is testing a new drug to see if it is safe and effective in treating cancer. The drug is designed to target a protein called GSK-3β, which is found in many different types of cancer cells.
Image of Moores Cancer Center, UCSD in La Jolla, United States.

Atezolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1 & 2
This trial is testing a new drug, DSP107, as a possible treatment for advanced solid tumors. The trial will assess the safety and efficacy of DSP107 given alone or in combination with atezolizumab.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Eflornithine +1 More

Enzyme Inhibitor

Recruiting1 awardPhase 3
This trial will test a combination of drugs to see if they are effective in reducing the chance of cancer recurrence or developing new cancers.
Image of Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro in Jonesboro, United States.

Oxaliplatin +4 More

Chemotherapy

Recruiting2 awardsPhase 3
This trial is testing a combination of chemotherapy drugs, bevacizumab, and atezolizumab to treat patients with metastatic colorectal cancer.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.